NEW THERAPIESSTOCKHOLM-- Alzheimer's researchers gathered here last month with a sense of urgency and optimism about possible treatments--and perhaps preventions--for the mind-robbing disease. The 4000 attendees heard about progress on several fronts, including possible vaccines and treatments aimed at either blocking formation of b amyloid, a small peptide thought to trigger the loss of brain neurons, or at dissolving the abnormal b-amyloid deposits that are a hallmark of the disease. This special focus also explores a debate over which drugs to test in a prevention trial.
No takes yet. Share an insight, caveat, or question.
Laura Helmuth (2002) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: